A Study to Evaluate the Duration of LASTACAFT® in Acute Allergic Conjunctivitis

NCT01470118 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

127

Enrollment

INDUSTRY

Sponsor class

Conditions

Conjunctivitis, Allergic

Interventions

DRUG: alcaftadine 0.25% ophthalmic solution
DRUG: olopatadine 0.2% ophthalmic solution
DRUG: dextran 70 0.1%/hydroxypropyl methylcellulose 0.3%

Sponsor

Allergan